Evox Therapeutics Limited – Trademark Portfolio
Entity Type: 99
Evox Therapeutics Limited holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include EXOEDIT, EXOFREE, DELIVEREX, EXOCORRECT, and EXOREPLACE.
Oxford Science Park, Medawar Centre,
2nd Floor East Building, Robert Robinson
Showing of trademarks Trademarks
Trademark Classifications
Evox Therapeutics Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Evox Therapeutics Limited have?
Evox Therapeutics Limited has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 1 abandoned.
What trademark classes does Evox Therapeutics Limited file in?
Evox Therapeutics Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Evox Therapeutics Limited's most well-known trademarks?
Evox Therapeutics Limited's registered trademark portfolio includes well-known marks such as EXOEDIT, EXOFREE, DELIVEREX, EXOCORRECT, and EXOREPLACE. These are among 6 currently registered trademarks in the portfolio.
What is Evox Therapeutics Limited's trademark registration success rate?
Evox Therapeutics Limited has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 2 applications are pending review.